NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 1 | ORGANIZATION
AND DESCRIPTION OF BUSINESS |
On
May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally
formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger
Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware
corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12,
2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing
as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.”
to “QPAGOS”.
Pursuant to
the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding
immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001
per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company
assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for
an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing
of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder
to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained
500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900
shares of Common Stock which represented approximately 91% of the outstanding Common Stock.
The
Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes.
As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated
as the acquired entity for accounting and financial reporting purposes.
Qpagos
Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos,
S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities
were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts
with, and Redpag was formed to deploy and operate kiosks as a distributor.
On
June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October
31 to December 31.
On November
1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally,
and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada
to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse
Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined
into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common
Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.
On
December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000
shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant
to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated
as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed
on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the
Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations,
currently based in Carmel By The Sea, California.
INNOVATIVE
PAYMENT SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 1 | ORGANIZATION
AND DESCRIPTION OF BUSINESS (continued) |
| b) | Description
of current business |
The
Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form
and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently
operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay,
which is focused on individual customers, was first launched in December 2021 and its commercial launch has continued during 2022. Previously
the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends
to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps
used via smartphones.
The
Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on
June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution
for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together
with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings.
The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase
price of $300,000 for each 1% acquired.
On
August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns
a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known
as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico
and other countries.
| 2 | ACCOUNTING
POLICIES AND ESTIMATES |
The
accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S.
GAAP”).
All
amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.
| b) | Principles of Consolidation |
The
consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting
interest. All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.
The
entities included in these consolidated financial statements are as follows:
Innovative
Payment Solutions, Inc. - Parent Company
Beyond
Fintech Inc., 51% owned.
The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which
are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management
bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues
and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular,
significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived
investments, the fair value of warrants and stock options granted for services or compensation, derivative liabilities, the valuation
allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from our estimates.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
| 2 | ACCOUNTING POLICIES AND
ESTIMATES (continued) |
Certain
conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only
be resolved when one or more future events occur or fail to occur.
The
Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.
If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can
be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment
indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated,
then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would
be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in
which case the guarantee would be disclosed.
| e) | Fair Value of Financial Instruments |
The
Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies
the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs
used in measuring fair value as follows:
Level
1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
Level
2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.
Level
3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.
The
carrying amounts reported in the balance sheets for the investment in Vivi Holdings Inc., was evaluated at fair value using Level 3 Inputs
based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings, Inc. Vivi Holdings Inc., does not
have sufficient information available to assess the current market price of its equity.
The
carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued
liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company
has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented
on the balance sheets at fair value in accordance with the accounting guidance.
ASC
825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities
at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless
a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should
be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly
basis and report any movements thereon in earnings.
| f) | Risks and Uncertainties |
The
Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory,
and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which
has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets,
lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income
markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors
and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and
financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable
terms.
The
Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary
measures, and rates and methods of taxation, among other things.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
| 2 | ACCOUNTING POLICIES AND
ESTIMATES (continued) |
| g) | Recent accounting pronouncements |
The Financial Accounting Standards Board
(“FASB”) issued additional updates during the year ended December 31, 2022. None of these standards are either applicable
to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated
financial statements upon adoption.
No segmental information
is required as the Company has only one operating segment.
| i) | Cash and Cash Equivalents |
The
Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
At December 31, 2022 and 2021, respectively, the Company had no cash equivalents.
The
Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution
in the United States. The balance at times may exceed federally insured limits. At December 31, 2022 and 2021, the balance exceed the
federally insured limit by $120,580 and $5,117,551, respectively.
| j) | Accounts Receivable and Allowance for Doubtful Accounts |
Accounts
receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the
related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based
on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an
integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state
of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates.
Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible
are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously
written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December
31, 2022 and 2021.
The
Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values.
The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar
investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity
securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured
during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation
methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and
obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t
result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%,
and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset
at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is
evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.
The
Company recorded an impairment charge of $1 and $0 on its non-marketable equity securities for the years ended December 31,
2022 and 2021, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date,
by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a
significant risk that Vivi may not be able to meet its obligations.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
| 2 | ACCOUNTING POLICIES AND
ESTIMATES (continued) |
Plant
and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized
and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated
useful lives of the assets are as follows:
Description |
|
Estimated Useful Life |
|
|
|
Kiosks |
|
7 years |
|
|
|
Computer equipment |
|
3 years |
|
|
|
Leasehold improvements |
|
Lesser of estimated useful life or life of lease |
|
|
|
Office equipment |
|
10 years |
The
cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation
are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.
Assets
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net
cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the fair value of the assets.
The
Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.
The
Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that
reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the
sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue
to be recognized as it fulfills its obligations under each of its revenue transactions:
| i. | identify the contract with a
customer; |
| ii. | identify the performance obligations
in the contract; |
| iii. | determine the transaction price; |
| iv. | allocate the transaction price
to performance obligations in the contract; and |
| v. | recognize revenue as the performance
obligation is satisfied. |
The
Company had minimal revenues of $847 and $0 during the years ended December 31, 2022 and 2021, respectively.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
| 2 | ACCOUNTING POLICIES AND
ESTIMATES (continued) |
| o) | Share-Based Payment Arrangements |
Generally,
all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at
their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based
compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the
fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded
in operating expenses in the consolidated statement of operations.
Prior
to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate
of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions
of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are
complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.
Where
equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value
of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions
have been used as the fair value for any share-based equity payments.
Where
equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated
from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used
in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar
maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets;
the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.
Subsequent
to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock
as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.
ASC
815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and
account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic
characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and
risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not
re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in
earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative
instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed
to be conventional, as described.
The
Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.
Income
taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities
are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using
the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on
available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes
as interest expense or penalties expense. As of December 31, 2022 and December 31, 2021, there have been no interest or penalties incurred
on income taxes.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
| 2 | ACCOUNTING POLICIES AND
ESTIMATES (continued) |
Comprehensive
income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding
transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss)
for the periods presented.
| s) | Reclassification of prior
year presentation |
Certain
prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on
the reported results of operations.
|
3 |
LIQUIDITY MATTERS AND GOING CONCERN |
The
Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”)
applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near
future. For and as of the year ended December 31, 2022, the Company had a net loss of $10,331,424. In connection with preparing the consolidated
financial statements for the year ended December 31, 2022, management evaluated the risks described in Note 2(f) above on the Company’s
business and its future liquidity for the next twelve months from the date of issuance of these financial statements.
The accompanying financial statements for the period ended
December 31, 2022 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue
as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream
and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity
securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of
its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to
delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability
to successfully secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements
do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
The Company has determined that there is substantial doubt
about their ability to continue as a going concern.
On
August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross
proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company
owns 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022, an additional
$41,320 on software to further enhance the Beyond Wallet product offering.
During
the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay
wallet, and during the year ended December 31, 2022, an additional $1,127,400, including warrants issued to Frictionless valued at $348,938
(note 5 and 11), was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.
| |
December 31, 2022 | | |
December 31, 2021 | |
| |
Cost | | |
Accumulated
amortization | | |
Net Book
Value | | |
Net book
value | |
Purchase Technology – Beyond Wallet | |
$ | 291,320 | | |
$ | - | | |
$ | 291,320 | | |
$ | 250,000 | |
Purchased Technology - IPSIPay | |
| 1,502,400 | | |
| (100,909 | ) | |
| 1,401,491 | | |
| 375,000 | |
| |
$ | 1,793,720 | | |
$ | (100,909 | ) | |
$ | 1,692,811 | | |
$ | 625,000 | |
Amortization expense was $100,909
and $0 for the years ended December 31, 2022 and 2021, respectively.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
Investment
in Frictionless Financial Technologies Inc.
On
June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common
shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed
to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment Software as a Service solution for use
by the Company as a digital payment platform that enables payments within the United states and abroad, including Mexico, together with
a service agreement providing a full suite of product services to facilitate to Company’s anticipated product offerings.
Pursuant
to the SPA, the Company agreed to issue a non-restricted, non-dilutable, five year warrant to purchase 30,000,000 shares
of common stock in the Company at an exercise price of $0.15 per share based on the delivery of the financial payment software in
accordance with the SPA. On December 30, 2022, the Company issued a warrant to Frictionless in satisfaction of this obligation. Due to
the pricing of financings undertaken by the Company between the date of the SPA and the date the warrant was granted, the exercise price
of the warrant was set upon issuance at $0.0115 per share. Further, the warrant issued to Frictionless was for restricted shares
of common stock and the “non-dilutable” provision was omitted. The warrant was valued at $348,938 on the date of grant and
was capitalized to purchased technology on the date of grant.
The
Company has the right to appoint and has appointed, one member to the board of directors of Frictionless, which appointee will remain
on the board as long as the Company is the holder of the Frictionless common stock.
The
Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase
price of $300,000 for each 1% acquired.
The
shares in Frictionless are unlisted as of December 31, 2022.
Investment
in Vivi Holdings, Inc.
Effective
December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corp, together with its 99.9% ownership
interest of Qpagos Corporations’ two Mexican entities: QPagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to
Vivi.
As
consideration for the disposal Vivi issued an aggregate of 2,250,000 Shares of its common stock as follows: 2,047,500 Shares
to the Company; 56,250 Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Shares to the Company’s
designee, the Joseph W. & Patricia G. Abrams Family Trust; and 112,500 Shares to the Company’s designee, Mr. Gaston
Pereira.
Due
to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed
of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.
As
of December 31, 2022 and 2021, the Company impaired the carrying value of the investment in Vivi Holdings, Inc by $1 and $0, respectively,
based on Vivi’s indicated timeline for its proposed IPO and fund raising activities, largely impacted by the COVID-19 pandemic.
The total impairment as of December 31, 2022 and 2021 was $1,019,961 and $1,019,960.
The
shares in Vivi Holdings, Inc., are unlisted as of December 31, 2022.
| |
December 31, 2022 | | |
December 31, 2021 | |
Investment in Frictionless Financial Technologies, Inc. | |
$ | 500,000 | | |
$ | 500,000 | |
Investment in Vivi Holdings, Inc. | |
| - | | |
| 1 | |
| |
$ | 500,000 | | |
$ | 500,001 | |
The
Company entered into a real property lease for office and warehouse space located at 19355 Business Center Drive in Northridge California,
Los Angeles County. The lease commenced on February 15, 2020 and expired on February 28, 2022, monthly rental expense was $3,945 per
month with no escalations during the term of the lease.
The
initial value of the right-of-use asset was $86,741 and the operating lease liability was $86,741. The Company monitors for events
or changes in circumstances that require a reassessment of its lease. When a reassessment results in the remeasurement of a lease liability,
a corresponding adjustment is made to the carrying amount of the corresponding right-of-use asset unless doing so would reduce the carrying
amount of the right-of-use asset to an amount less than zero. In that case, the amount of the adjustment that would result in a negative
right-of-use asset balance is recorded as a loss in the statement of operations.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
Effective
June 1, 2021, the Company entered into a Mutual Termination of Lease Agreement with the landlord. The security deposit of $4,000 was
forfeited.
On
March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel
By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following
the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January
1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088.
The
Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.
Total
Lease Cost
Individual
components of the total lease cost incurred by the Company is as follows:
| |
Year ended December 31, 2022 | | |
Year ended December 31, 2021 | |
Operating lease expense | |
$ | 57,600 | | |
$ | 74,803 | |
Other lease
information:
| |
Year ended December 31, 2022 | | |
Year ended December 31, 2021 | |
Cash paid for amounts included in the measurement of lease liabilities | |
| | |
| |
Operating cash flows from operating leases | |
$ | (57,600 | ) | |
$ | (74,803 | ) |
| |
| | | |
| | |
Remaining lease term – operating lease | |
| Monthly | | |
| 3 months | |
Small
Business Administration Disaster Relief loan
On
July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75%
per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and
principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be
used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.
The
company has accrued interest of $13,978 and $8,353 on this loan as of December 31, 2022 and 2021, respectively.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
On February
16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”)
and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from
Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”
and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original
Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise
price of $0.24 per share.
In terms of
the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16,
2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”)
to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted
for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling
$920,392 as a component of the loss on convertible debt.
The Exchange
Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but
not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted
for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange
Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation
to reserve such number of shares for future issuance.
Notes payable
consists of the following:
Description | |
Interest
Rate | | |
Maturity date | |
Principal | | |
Accrued
Interest | | |
December 31,
2022
Amount, net | | |
December 31,
2021
Amount, net | |
Cavalry Fund I LP | |
| 10 | % | |
December 30, 2023 | |
| 482,000 | | |
| 134 | | |
| 482,134 | | |
| - | |
Mercer Street Global Opportunity Fund, LLC | |
| 10 | % | |
December 30, 2023 | |
| 482,000 | | |
| 134 | | |
| 482,134 | | |
| - | |
Total convertible notes payable | |
| | | |
| |
$ | 964,000 | | |
$ | 268 | | |
$ | 964,268 | | |
$ | - | |
Interest
expense totaled $268 for the year ended December 31, 2022.
| 9 | CONVERTIBLE NOTES PAYABLE |
December
2022 Note Amendment Transaction
On February
16, 2021, we entered into separate SPAs with each of Cavalry and Mercer, pursuant to which we received $500,500 and $500,500 from Cavalry
and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”)
in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued
to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock (the “Common Stock”) at an
exercise price of $0.24 per share. Cavalry and Mercer are Selling Stockholders listed in this prospectus.
The Original
Warrants are discussed in note 8 above.
The Company
twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the
Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to
November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and
due to Cavalry and Mercer under their respective Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year
warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of common stock at an exercise price of
$0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except
for difference in exercise price.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 9 | CONVERTIBLE NOTES PAYABLE
(continued) |
On December
30, 2022, the Company again extended the maturity dates of each of the Notes to December 30, 2023. Each of Cavalry and Mercer entered
into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:
| (1) | The conversion price of the
Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give
the passage of the November 16, 2022 maturity date of the Notes). As a result of this change in conversion price, under the existing
terms of the Notes, the 3,000,000 shares of common stock underlying the Extension Warrants was increased to 39,130,435 shares; |
| (2) | The Original Warrants issued
on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange
Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date
of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu
of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits,
dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata
portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such
number of shares for future issuance; |
| (3) | Each of Cavalry and Mercer
agreed (i) not to convert all or any portion of the Notes until after March 30, 2023 and (ii) waive any events of default under the Notes
and the SPAs; |
| (4) | Certain other warrants held
by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the
common stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share;
and |
| (5) | The company was obligated to
register the shares of common stock underlying the Notes and the shares underlying all warrants held by Cavalry and Mercer for resale
with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation. |
The parties
also acknowledged that the principal and accrued interest under the Notes as of December 28, 2022 is equal to an aggregate of $2,264,784,
or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Notes, certain
other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our
common stock underlying the Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant
to the filed registration statement.
The amendments
to the convertible debt were evaluated in terms of ASC470, Debt, to determine if the amendments to the convertible debt were considered
a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414,
the reduction in the conversion price of the convertible notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a
Black-Scholes valuation model, the issuance of additional warrants to the convertible note holders valued at $238,182 using a Black-Scholes
valuation model and the conversion of certain warrants to notes payable, resulting in an additional charge of $920,392, consisting of
a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (Note 8 above) and the value of full rachet provisions
of certain of the warrants issued to the convertible note holders amounting to $841,003, see note 12 below, the amendment of the convertible
notes was determined to be a debt extinguishment.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 9 | CONVERTIBLE NOTES PAYABLE
(continued) |
Convertible
notes payable consists of the following:
Description | |
Interest Rate | | |
Maturity date | |
Principal | | |
Accrued Interest | | |
Unamortized debt discount | | |
December 31,
2022 Amount, net | | |
December 31,
2021 Amount, net | |
Cavalry Fund I LP | |
| 10 | % | |
December 30, 2023 | |
| 1,091,754 | | |
| 41,547 | | |
| - | | |
| 1,133,301 | | |
| 548,872 | |
| |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Mercer Street Global Opportunity Fund, LLC | |
| 10 | % | |
December 30, 2023 | |
| 1,091,754 | | |
| 41,547 | | |
| - | | |
| 1,133,301 | | |
| 548,872 | |
| |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Bellridge Capital LP | |
| 10 | % | |
February 16, 2022 | |
| - | | |
| - | | |
| - | | |
| - | | |
| 863,609 | |
| |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Total convertible notes payable | |
| | | |
| |
$ | 2,183,508 | | |
$ | 83,094 | | |
$ | - | | |
$ | 2,266,602 | | |
$ | 1,961,353 | |
Interest
expense totaled $193,886 and $221,930 for the years ended December 31, 2022 and 2021, respectively.
Amortization
of debt discount totaled $263,200 and $3,653,652 for the years ended December 31, 2022 and 2021, respectively.
The
convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time.
The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the
common stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative
financial liability.
Cavalry
Fund LLP
| ● | On February 16, 2021, the Company closed a transaction with Cavalry, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share. |
As described more fully above, the maturity
date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for
the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent
(20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15
per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of
the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after
March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of
common stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission
and filed the registration statement to satisfy the Company’s registration obligation.
The balance of the Cavalry Note plus
accrued interest at December 31, 2022 was $1,133,301.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 9 | CONVERTIBLE NOTES PAYABLE
(continued) |
Mercer
Street Global Opportunity Fund, LLC
| ● | On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share. As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation. The balance of the Mercer Note plus accrued interest at December 31, 2022 was $1,133,301. |
Bellridge
Capital LP.
| ● | On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and which matured on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of common stock at an initial exercise price of $0.24 per share. The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250 and penalty interest of $247,062 recorded as a loss on convertible debt, thereby extinguishing the Bellridge Note. |
Certain
of the short-term convertible notes disclosed in note 9 above and certain warrants disclosed in note 11 below, have variable priced conversion
rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes
and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and
any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of
the convertible notes using a Black-Scholes valuation model.
On
December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described
under note 9 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory
notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension
Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a
repricing of certain of these warrants.
The
derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market
immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the
extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant
Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible
notes charge in the statement of operations.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 10 | DERIVATIVE LIABILITY (continued) |
The
net movement on the derivative liability for the year ended December 31, 2022 was as follows; net mark-to-market release of derivative
liability of $411,752, new derivative liability arising on warrants issued of $238,182 and additional derivative liability arising on
the Note Amendment of $2,317,051. The value of the derivative liability in each instance above was determined by using a Black-Scholes
valuation model.
The
following assumptions were used in the Black-Scholes valuation model:
| |
Year
ended
December 31,
2022 | | |
Year
ended
December 31,
2021 | |
Conversion price | |
$ | 0.0115 to $0.15 | | |
$ | 0.05 to $0.24 | |
Risk free interest rate | |
| 0.79 to 4.73 | % | |
| 0.05 to 1.12 | % |
Expected life of derivative liability | |
| 1.5 to 59 months | | |
| 1.6 to 49.6 months | |
Expected volatility of underlying stock | |
| 120.49 to 258.3 | % | |
| 161.19 to 215.33 | % |
Expected dividend rate | |
| 0 | % | |
| 0 | % |
The
movement in derivative liability is as follows:
| |
December 31, 2022 | | |
December 31, 2021 | |
Opening balance | |
$ | 407,161 | | |
$ | 2,966,416 | |
Derivative financial liability arising from convertible note and warrants | |
| 238,182 | | |
| 2,569,000 | |
Derivative financial liability arising on note amendment included in loss on convertible notes | |
| 2,317,051 | | |
| - | |
Fair value adjustment to derivative liability | |
| (411,752 | ) | |
| (5,128,255 | ) |
| |
$ | 2,550,642 | | |
$ | 407,161 | |
The Company has total authorized Common
Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 376,901,679 and 367,901,679 shares
of Common Stock issued and outstanding as of December 31, 2022 and December 31, 2021, respectively.
In terms of debt conversion notices
received between January 5, 2021 and February 23, 2021, the Company issued an aggregate of 61,793,616 shares of common stock
for the conversion of $2,259,221 of convertible debt and interest thereon, realizing a loss on conversion of $5,498,820.
In terms of warrant exercise notices
received between February 18, 2021 and June 23, 2021, the Company issued 60,186,982 shares of common stock for gross proceeds
of $3,009,349.
On March 17, 2021, the Company,
entered into Securities Purchase Agreements with several institutional investors, pursuant to which the Company agreed to sell to the
Investors in a private placement (i) 30,333,334 shares of its common stock (the “Shares”) and (ii) warrants (the “Warrants”)
to purchase up to an aggregate of 15,166,667 shares of its common stock for gross proceeds of approximately $4,550,000. The combined purchase
price for one share of common stock and associated Warrant is $0.15.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY (continued) |
| a. | Common Stock (continued) |
Pursuant to an engagement letter
dated as of March 6, 2021, by and between the Company and H.C. Wainwright & Co., LLC (“Wainwright”), the Company engaged
Wainwright to act as the Company’s exclusive placement agent in connection with the private placement. Pursuant to the engagement
agreement, the Company agreed to pay Wainwright a cash fee of 8.0% of the gross proceeds raised by the Company in the private placement.
The Company also agreed to pay Wainwright (i) a management fee equal to 1.0% of the gross proceeds raised in the private placement;
(ii) $35,000 for non-accountable expenses and (iii) up to $50,000 for fees and expenses of legal counsel and other out-of-pocket expenses.
In addition, the Company agreed to issue to Wainwright (or its designees) placement agent warrants (the “Placement Agent Warrants”)
to purchase a number of shares equal to 8.0% of the aggregate number of Shares sold under the Purchase Agreement or warrants to purchase
an aggregate of up to 2,426,667 shares of the Company’s common stock. The Placement Agent Warrants generally will have the same
terms as the Warrants, except they will have an exercise price of $0.1875.
On April 5, 2021, the Board of directors
approved advisory board agreements with four individuals, each agreement for a period of two years form the effective
date of the agreement and may be terminated by each party with 30 days’ notice. As compensation the Company awarded
each advisory board member 2,000,000 restricted shares of common stock, the restricted shares of common stock vest as to
75% on the effective date and 25% on the anniversary date of the agreement.
On July 22, 2021, the Board of directors
approved the issuance of 7,000,000 shares of common stock to board members that were appointed during the year. In Addition,
a further 300,000 shares of common stock were issued to an employee of the Company and a further 3,650,000 shares
of common stock were issued to various consultants.
On July 8, 2022, the Company entered
into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan;
(ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s
behalf with potential and actual commercial partners.
The Company issued 2,000,000 shares
of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued
at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement,
commencing on August 1, 2022.
On July 8, 2022, the Company entered
into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s
business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface
on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock
as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the
date of grant.
On July 11, 2022, the Board approved
the issuance of 2,000,000 restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief
Financial Officer. These shares were valued at $110,000 at the date of grant.
On August 5, 2022, the Board approved
the issuance of 3,000,000 shares of Common Stock to Samad Harake or his designees as compensation for the services rendered
which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued
at $165,000 at the date of grant.
| b. | Restricted stock awards |
On
December 15, 2020, in terms of an employment agreement entered into with an employee, the Company granted 2,500,000 restricted
shares of which 1,000,000 vested on January 1, 2021 and the remaining 1,500,000 shares vest over a period of two years. The 1,500,000 shares
of unvested restricted stock which was not physically issued to the employee were not earned due to the cessation of employment with the
Company.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY (continued) |
| b. | Restricted stock awards
(continued) |
A
summary of restricted stock activity during the period January 1, 2021 to December 31, 2022 is as follows:
| |
Total restricted shares | | |
Weighted average fair market value per share | | |
Total unvested restricted shares | | |
Weighted average fair market value per share | | |
Total vested restricted shares | | |
Weighted average fair market value per share | |
Outstanding January 1, 2021 | |
| 20,495,000 | | |
$ | 0.049 | | |
| 15,371,250 | | |
$ | 0.049 | | |
| 5,123,750 | | |
$ | 0.049 | |
Granted and issued | |
| 2,500,000 | | |
| 0.050 | | |
| 2,500,000 | | |
| 0.050 | | |
| - | | |
| - | |
Forfeited/Cancelled | |
| (1,500,000 | ) | |
| (0.050 | ) | |
| (1,500,000 | ) | |
| (0.050 | ) | |
| - | | |
| - | |
Vested | |
| - | | |
| - | | |
| (6,123,750 | ) | |
| (0.049 | ) | |
| 6,123,750 | | |
| 0.049 | |
Outstanding December 31, 2021 | |
| 21,495,000 | | |
$ | 0.049 | | |
| 10,247,500 | | |
$ | 0.049 | | |
| 11,247,500 | | |
$ | 0.049 | |
Granted and issued | |
| 2,000,000 | | |
| 0.055 | | |
| - | | |
| - | | |
| 2,000,000 | | |
| 0.055 | |
Forfeited/Cancelled | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Vested | |
| - | | |
| - | | |
| (5,123,750 | ) | |
| (0.049 | ) | |
| 5,123,750 | | |
| 0.049 | |
Outstanding December 31, 2022 | |
| 23,495,000 | | |
$ | 0.050 | | |
| 5,123,750 | | |
$ | 0.049 | | |
| 18,371,250 | | |
$ | 0.050 | |
The
restricted stock granted, issued and exercisable at December 31, 2022 is as follows:
| | |
Restricted Stock Granted | | |
Restricted Stock Vested | |
Grant date Price | | |
Number Granted | | |
Weighted Average Fair Value per Share | | |
Number Vested | | |
Weighted Average Fair Value per Share | |
$ | 0.049 | | |
| 20,495,000 | | |
$ | 0.049 | | |
| 15,371,250 | | |
$ | 0.049 | |
$ | 0.050 | | |
| 1,000,000 | | |
| 0.050 | | |
| 1,000,000 | | |
| 0.050 | |
$ | 0.055 | | |
| 2,000,000 | | |
| 0.055 | | |
| 2,000,000 | | |
| 0.055 | |
| | | |
| 23,495,000 | | |
$ | 0.050 | | |
| 18,371,250 | | |
$ | 0.050 | |
The Company has recorded
an expense of $361,064 and $301,064 for the years ended December 31, 2022 and 2021, respectively.
The
Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock
was issued and outstanding as of December 31, 2022 and 2021, respectively.
Effective
July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation
(“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will
act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual
payment processing and money remittance business and the Company’s related products and services.
The
Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier
termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement,
including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains
other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive
products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY (continued) |
As
compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i)
a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand
Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during
the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior
to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of
the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective
Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation
of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise
Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration
statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.
On
August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note
holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration
date of August 30, 2027. The fair value of these warrants was $238,182 which was recorded as a loss on convertible notes and a corresponding
derivative, determined by using a Black-Scholes valuation model.
On
December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of common stock in
the Company at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938
determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant.
On
December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In
terms of the Note Amendment Transaction the following occurred:
| ● | The
warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957
for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each,
as disclosed in note 8 above; |
|
● |
The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. |
|
● |
An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt. |
The
fair value of the warrants granted, issued and repriced, as described above, were determined by using a Black Scholes valuation model
using the following assumptions:
| |
Year ended
December 31,
2022 | |
Exercise price | |
$ | 0.00115 to 0.15 | |
Risk free interest rate | |
| 3.14 to 3.27 | % |
Expected life | |
| 3 to 5 years | |
Expected volatility of underlying stock | |
| 182.6 to 199.2 | % |
Expected dividend rate | |
| 0 | % |
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY (continued) |
A
summary of warrant activity during the period January 1, 2021 to December 31, 2022 is as follows:
| |
Shares
Underlying
Warrants | | |
Exercise price per
share | | |
Weighted
average
exercise price | |
Outstanding January 1, 2021 | |
| 51,188,572 | | |
$ | 0.05 | | |
$ | 0.05 | |
Granted | |
| 66,302,515 | | |
| 0.05 to 0.24 | | |
| 0.16 | |
Forfeited/Cancelled | |
| (20,000,000 | ) | |
| 0.24 | | |
| 0.24 | |
Exercised | |
| (60,186,982 | ) | |
| 0.05 | | |
| 0.05 | |
Outstanding December 31, 2021 | |
| 37,304,105 | | |
$ | 0.05 – 0.1875 | | |
$ | 0.12 | |
Granted | |
| 51,000,000 | | |
| 0.0115 – 0.15 | | |
| 0.02 | |
Increase in warrants due to debt amendment full rachet trigger | |
| 72,260,870 | | |
| 0.0115 | | |
| 0.01 | |
Cancelled on debt amendment | |
| (4,973,914 | ) | |
| 0.15 | | |
| 0.15 | |
Exercised | |
| - | | |
| - | | |
| - | |
Outstanding December 31, 2022 | |
| 155,591,061 | | |
$ | 0.05 – 0.1875 | | |
$ | 0.03 | |
The
warrants outstanding and exercisable at December 31, 2022 are as follows:
| | |
Warrants Outstanding | | |
Warrants Exercisable | |
Exercise Price | | |
Number Outstanding | | |
Weighted Average Remaining Contractual life in years | | |
Weighted Average Exercise Price | | |
Number Exercisable | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual life in years | |
$ | 0.0115 | | |
| 121,997,727 | | |
| 4.57 | | |
| | | |
| 121,997,727 | | |
| | | |
| 4.57 | |
$ | 0.0345 | | |
| 15,000,000 | | |
| 2.52 | | |
| | | |
| 9,375,000 | | |
| | | |
| 2.52 | |
$ | 0.05 | | |
| 1,000,000 | | |
| 0.14 | | |
| | | |
| 1,000,000 | | |
| | | |
| 0.14 | |
$ | 0.15 | | |
| 15,166,667 | | |
| 3.21 | | |
| | | |
| 15,166,667 | | |
| | | |
| 3.21 | |
$ | 0.1875 | | |
| 2,426,667 | | |
| 3.21 | | |
| | | |
| 2,426,667 | | |
| | | |
| 3.21 | |
| | | |
| 155,591,061 | | |
| 4.19 | | |
$ | 0.03 | | |
| 149,966,061 | | |
$ | 0.03 | | |
| 4.25 | |
The
warrants outstanding have an intrinsic value of $60,999 and $0 as of December 31, 2022 and 2021, respectively.
On
June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the
interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company
with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire
a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate
objectives. The Plan terminates after a period of ten years in June 2028.
The
Plan is administered by the board of directors or a Committee appointed by the Board of Directors who have the authority to administer
the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.
The
maximum number of securities available under the Plan is 800,000 shares of common stock. The maximum number of shares of common
stock awarded to any individual during any fiscal year may not exceed 100,000 shares of common stock.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY
(continued) |
| e. | Stock options (continued) |
On
October 22, 2021, the Company (with the approval of the Company’s shareholders) established its 2021 Stock Incentive Plan (“2021
Plan”). The purpose of the 2021 Plan is to promote the interests of the Company and the stockholders of the Company by providing
directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards
to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term
success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The 2021 Plan terminates
after a period of ten years in August 2031.
The
2021 Plan is administered by the board of directors or a Compensation Committee appointed by the Board of Directors who have the authority
to administer the 2021 Plan and to exercise all the powers and authorities specifically granted to it under the 2021 Plan.
The
maximum number of securities available under the 2021 Plan is 53,000,000 shares of common stock.
Under
the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation
rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.
On
February 22, 2021, the board awarded each of its directors, James Fuller and Andrey Novikov, options under the Company’s 2018 Stock
Incentive Plan to purchase 208,333 shares of the Company’s common stock. The options are exercisable for a period of ten
years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.
On
July 22, 2021, the board of directors authorized the reduction in the exercise price of the options exercisable for 208,333 shares
of common stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share, resulting in an immediate
compensation charge of $6, the remaining terms of the option were unchanged.
On
August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous
executive employment agreement whereby the 20,000,000 warrants previously issued to Mr. Corbett were cancelled and as a replacement
for the warrants, he was granted options to purchase 20,000,000 shares of common stock of the Company at a per share exercise
price of $0.15. The options are exercisable for a period of ten years from the date of grant, vesting as to 50% on grant date and the
remaining 50%, equally over a period of 36 months. The option expense for the year ended December 31, 2022 was $266,348.
In
terms of an employment agreement dated August 16, 2021, on August 31, 2021, the Board awarded Richard Rosenblum, the Company’s Chief
Financial Officer an option to purchase 10,000,000 shares of the Company’s common stock at an exercise price of $0.15 per
share. The options are exercisable for a period of ten years from the date of grant, vesting as to 50% on grant date and the remaining
50%, equally over a period of 36 months. The option expense for the year ended December 31, 2022 was $111,510.
On
July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to
the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense
of $823,854 for the year ended December 31, 2022.
On
September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each
of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per
share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 11 | STOCKHOLDERS’ EQUITY
(continued) |
| e. | Stock options (continued) |
The
fair value of the options granted and issued were determined by using a Black Scholes valuation model using the following assumptions:
| |
Year
ended
December 31,
2022 | |
Exercise price | |
$ | 0.04 to 0.15 | |
Risk free interest rate | |
| 2.99 to 3.42 | % |
Expected life | |
| 10.0 years | |
Expected volatility of underlying stock | |
| 206.4 to 208.4 | % |
Expected dividend rate | |
| 0 | % |
A
summary of option activity during the period January 1, 2021 to December 31, 2022 is as follows:
| |
Shares
Underlying
options | | |
Exercise
price per
share | | |
Weighted
average
exercise
price | |
Outstanding January 1, 2021 | |
| 100,000 | | |
$ | 0.40 | | |
$ | 0.40 | |
Granted | |
| 30,416,666 | | |
| 0.15 – 0.24 | | |
| 0.15 | |
Forfeited/Cancelled | |
| - | | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | | |
| - | |
Outstanding December 31, 2021 | |
| 30,516,666 | | |
$ | 0.15 to 0.40 | | |
$ | 0.15 | |
Granted | |
| 15,800,000 | | |
| 0.04 – 0.15 | | |
| 0.14 | |
Forfeited/Cancelled | |
| - | | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | | |
| - | |
Outstanding December
31, 2022 | |
| 46,316,666 | | |
$ | 0.04 to 0.40 | | |
$ | 0.15 | |
The
options outstanding and exercisable at December 31, 2022 are as follows:
|
|
|
Options Outstanding |
|
|
Options Exercisable |
|
Exercise
Price |
|
|
Number
Outstanding |
|
|
Weighted
Average
Remaining
Contractual
life in years |
|
|
Weighted
Average
Exercise
Price |
|
|
Number
Exercisable |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
life in years |
|
|
0.04 |
|
|
|
800,000 |
|
|
|
9.71 |
|
|
|
|
|
|
|
800,000 |
|
|
|
|
|
|
|
9.71 |
|
|
0.15 |
|
|
|
45,208,333 |
|
|
|
8.94 |
|
|
|
|
|
|
|
35,625,000 |
|
|
|
|
|
|
|
9.00 |
|
|
0.24 |
|
|
|
208,333 |
|
|
|
8.15 |
|
|
|
|
|
|
|
208,333 |
|
|
|
|
|
|
|
8.15 |
|
|
0.40 |
|
|
|
100,000 |
|
|
|
5.99 |
|
|
|
|
|
|
|
100,000 |
|
|
|
|
|
|
|
5.99 |
|
|
|
|
|
|
46,316,666 |
|
|
|
8.94 |
|
|
$ |
0.15 |
|
|
|
36,733,333 |
|
|
$ |
0.15 |
|
|
|
9.01 |
|
The
options outstanding have an intrinsic value of $0 as of December 31, 2022 and 2021, respectively.
The
option expense was $1,233,682 and $1,382,639 for the years ended December 31, 2022 and 2021, respectively.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 12 | LOSS ON CONVERTIBLE NOTES |
The
loss on convertible notes consists of the following:
| |
December 31,
2022 | |
Penalty on cash settlement of convertible note | |
$ | 247,063 | |
Penalty on extension of maturity date of convertible notes | |
| 836,414 | |
Fair value of warrants issued to convertible note holders on extension of maturity date | |
| 238,182 | |
Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders | |
| 2,360,658 | |
Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608) | |
| 920,392 | |
| |
$ | 4,602,709 | |
Penalty
on cash settlement of convertible note
On February
4, 2022, the Company cash settled the outstanding balance, including early settlement penalty thereon of $247,063, of a convertible note
owing to Bellridge for gross proceeds of $1,235,313.
Penalty on extension
of maturity date of convertible notes
The Company
twice extended the maturity date of its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the
maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity
date extension to November 16, 2022, in terms of these extensions, the Company incurred penalties which increased the principle outstanding
of these convertible notes in the aggregate amount of $836,414.
Fair
value of warrants issued to convertible note holders on extension of maturity date
In addition
to the penalty on extension of maturity date on its indebtedness to each of Cavalry and Mercer, in consideration for the second extension
on August 30, 2022, the Company agreed to issue to each of Cavalry and Mercer a new five-year warrant to purchase an additional 3,000,000
shares of common stock at an exercise price of $0.15 per share. The fair value of these warrants were determined as $238,182 on August
30, 2022, using a Black-Scholes valuation model.
Fair value
of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants
issued to convertible note holders
On December
30, 2022, the Company again extended the maturity dates of each of the Notes to Cavalry and Mercer to December 30, 2023. Each of Cavalry
and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties
agreed that the conversion price of the Notes was reduced from $0.15 to $0.0115 per share and in addition, resulted in the 3,000,000 shares
of common stock underlying the Extension Warrants increasing to 39,130,435 shares, in terms of the full-rachet provisions in those warrant
agreements. The change in the conversion price and the increase in the number of warrant shares to be issued at the revised exercise price
of $0.0115per share, resulted in a derivative liability on December 30, 2022 of $2,340,580, determined by using a Black-Scholes valuation
model.
In addition
to this, certain other warrants outstanding had their conversion price reduced from $0.05 per share to $0.0115 per share in terms of their
warrant agreements, resulting in an additional derivative liability on December 30, 2022 of $20,079, determined by using a Black-Scholes
valuation model.
Value
of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)
On December
30, 2022, the Company also agreed to exchange the Original Warrants issued on February 16, 2021 to Cavalry and Mercer for 12-month non-convertible
promissory notes in the amount of $482,000 each. This resulted in an additional charge of $964,000, less the fair value of the derivative
liability of the Original warrants of $43,608, valued on December 30, 2022, using a Black-Scholes valuation model.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
The
Company’s operations are based in the US and currently enacted tax laws in the US are used in the calculation of income taxes.
Federal
Income Tax - United States
On
December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law
by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction
of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense
to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year
taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration,
one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign
earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation
expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and
changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the
reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various
states will conform to the newly enacted federal tax law.
Income
taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities
are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using
the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on
available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes
as interest expense or penalties expense. As of December 31, 2022 and 2021, there have been no interest or penalties incurred on income
taxes.
The
provision for income taxes consists of the following:
| |
Year ended
December 31,
2022 | | |
Year ended
December 31,
2021 | |
Current | |
| | |
| |
Federal | |
$ | | | |
$ | | |
State | |
| - | | |
| - | |
Foreign | |
| - | | |
| - | |
| |
$ | - | | |
$ | - | |
Deferred | |
| | | |
| | |
Federal | |
$ | - | | |
$ | - | |
State | |
| - | | |
| - | |
Foreign | |
| - | | |
| - | |
| |
$ | - | | |
$ | - | |
A
reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:
| |
Year ended December 31, 2022 | | |
Year ended December 31, 2021 | |
Continuing operations | |
| | |
| |
Tax expense at the federal statutory rate | |
$ | (2,169,599 | ) | |
$ | (3,043,932 | ) |
State tax expense, net of federal tax effect | |
| (324,289 | ) | |
| (409.279 | ) |
Permanent differences | |
| 1,194,446 | | |
| 1,813,210 | |
Prior year net operating loss true up | |
| (3,277 | ) | |
| (43,413 | ) |
| |
| (1,302,719 | ) | |
| (1,683,414 | ) |
Deferred income tax asset valuation allowance | |
| 1.302,719 | | |
| 1,683,414 | |
| |
$ | - | | |
$ | - | |
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 13 | INCOME TAXES (continued) |
Federal Income Tax - United
States (continued)
Significant
components of the Company’s deferred income tax assets are as follows:
| |
December 31, 2022 | | |
December 31, 2021 | |
Other | |
$ | 241,491 | | |
$ | 241,491 | |
Net operating losses | |
| 6,479,181 | | |
| 5,284,205 | |
Stock based compensation | |
| 511,142 | | |
| 403,399 | |
Valuation allowance | |
| (7,231,814 | ) | |
| (5,929,095 | ) |
Net deferred income tax assets | |
$ | - | | |
$ | - | |
The
valuation allowance for deferred income tax assets as of December 31, 2022 and December 31, 2021 was $7,231,814 and
$5,929,095, respectively. The net change in the deferred income tax assets valuation allowance was an increase of $1,302,719 and
is primarily attributable to tax operating losses realized during the current year.
As
of December 31, 2022, the prior three years remain open for examination by the federal or state regulatory agencies for purposes
of an audit for tax purposes.
As
of December 31, 2022, the Company had available for income tax purposes approximately $25.0 million in federal and $18.2 million
in state net operating loss carry forwards, which may be available to offset future taxable income. $3.5 million of the net operating
losses will begin to expire in 2034 and $21.5 million has an indefinite life. Due to the uncertainty of the utilization and recoverability
of the loss carryforwards and other deferred tax assets, Management has determined a full valuation allowance for the deferred tax assets
since it is more likely than not that the deferred tax assets will not be realizable.
The
Company’s ability to utilize the United States Federal operating loss carryforwards may be subject to an annual limitation if pursuant
to IRC Section 382/383 of the Internal Revenue Code of 1986, as amended, if a change of ownership has occurred. Management does not believe
if an ownership change has occurred under IRC Section 382/383, but is evaluating, if such change has occurred. If such change has occurred,
it is also possible that the loss carryforward could be eliminated.
The
Company is subject to taxation in the U.S. and CA state. U.S. federal income tax returns for 2019 and after, remain open to examination.
No income tax returns are currently under examination. As of December 31, 2022 and 2021, the Company does not have any unrecognized tax
benefits, and continues to monitor its current and prior tax positions for any changes. The Company recognizes penalties and interest
related to unrecognized tax benefits as income tax expense. For the years ended December 31, 2022 and 2021, there were no penalties or
interest recorded in income tax expense.
| 14 | EQUITY BASED COMPENSATION |
Equity based compensation
is made up of the following:
| |
Year ended
December 31,
2022 | | |
Year ended
December 31,
2021 | |
Incentive stock awards | |
$ | 1,594,746 | | |
$ | 6,011,601 | |
Securities issued for services rendered | |
| 333,000 | | |
| 1,781,150 | |
| |
$ | 1,927,746 | | |
$ | 7,792,751 | |
Basic
loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based
on basic shares as determined above plus common stock equivalents. The computation of diluted net loss per share does not assume the issuance
of common shares that have an anti-dilutive effect on net loss per share. For the years ended December 31, 2022 and 2021 all
warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 15 | NET LOSS PER SHARE (continued) |
Dilutive
shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because
their affect would have been anti-dilutive for the years ended December 31, 2022 and 2021 are as follows:
| |
Year ended December 31, 2022 (Shares) | | |
Year ended December 31, 2021 (Shares) | |
Convertible debt | |
| 197,095,902 | | |
| 13,626,666 | |
Stock options | |
| 46,316,666 | | |
| 30,516,666 | |
Warrants to purchase shares of common stock | |
| 155,591,061 | | |
| 37,304,104 | |
| |
| 399,003,629 | | |
| 81,477,436 | |
| 16 | RELATED PARTY TRANSACTIONS |
The
following transactions were entered into with related parties:
James
Fuller
On
February 22, 2021, the Board awarded James Fuller options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares
of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have
an exercise price of $0.24 per share.
On
July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000.
Additionally,
the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February
22, 2021, from $0.24 per share to $0.15 per share.
On
September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise
price of $0.04 per share.
The
option expense for Mr. Fuller was $7,993 and $45,804 for the years ended December 31, 2022 and 2021, respectively.
Mr. Fuller voluntarily resigned as
a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.
Andrey
Novikov
On
February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares
of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have
an exercise price of $0.24 per share.
On
May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective
as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer.
On November 11, 2022, with the recommendation of a special committee of disinterested members of the Board who had reviewed this matter,
the Board approved the formal termination of Mr. Novikov’s employment with the Company for “cause.”
William
Corbett
On
February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer,
as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise
price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense
for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 16 | RELATED PARTY TRANSACTIONS
(continued) |
William
Corbett (continued)
On
August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous
executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment
Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment
agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s
Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close
of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with
the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett
Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company
achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from
time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share
exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares
subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate
of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the
Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive
Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained
at the annual general meeting held on October 22, 2021.
In
addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification
Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted
by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement
of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the
August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs,
including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability
in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett
shall each bear its or his own attorney fees and costs.
On
July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise
price of $0.15 per share.
The
option expense for Mr. Corbett was $1,090,201 and $910,019 for the years ended December 31, 2022 and 2021, respectively.
Clifford
Henry
On
May 1, 2021, the Company appointed Mr. Henry to the Board.
On
July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.
Mr.
Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice.
This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and
related payments were terminated in September 2022.
On
September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common
Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.
The
option expense for Mr. Henry was $7,993 and $0 for the years ended December 31, 2022 and 2021.
Madisson
Corbett
On
May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief
Executive Officer and Chairman of the Board.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 16 | RELATED PARTY TRANSACTIONS
(continued) |
Madisson
Corbett (continued)
On
July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000.
On
September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of
Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.
The
option expense for Ms. Corbett was $7,993 and $0 for the years ended December 31, 2022 and 2021, respectively.
David
Rios
On
July 22, 2021, the Company appointed David Rios to the Board.
On
July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000.
On
September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares
of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.
The
option expense for Mr. Rios was $7,993 and $0 for the years ended December 31, 2022 and 2021.
Richard
Rosenblum
On
July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum
was elected to the Board to serve until the Company’s next annual meeting of shareholders and was subsequently appointed as the
Company’s Secretary.
On
July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”),
pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective
as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board,
unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024.
Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will
be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial
performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum
options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock,
as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock
exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest
on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period.
The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise
of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved
by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general
meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan.
If
Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause
(as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be
entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s
employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the
Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as
defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate
in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of
the Company.
INNOVATIVE PAYMENT
SOLUTIONS, INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
| 16 | RELATED PARTY TRANSACTIONS
(continued) |
Richard
Rosenblum (continued)
On
August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”)
with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option
to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value
of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted,
on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was
granted on August 31, 2021 at an exercise price of $0.15 per share.
In
addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr.
Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including
third-party claims and derivative claims and provides for advancement of expenses.
On
July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which
are vested.
The
option expense for Mr. Rosenblum was $111,514 and $381,006 for the years ended December 31, 2022 and 2021, respectively, using a Black-Scholes
valuation model..
| 17 | COMMITMENTS AND CONTINGENCIES |
The
Company has notes and convertible notes, disclosed under note 8 and 9 above, which mature on December 30, 2023. Should these notes not
be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.
Convertible
note funding
Between February
13, 2023 and February 23, 2023, the Company, entered into Securities Purchase Agreements (the “Securities Purchase Agreement”)
with 11 accredited investors, pursuant to which the Company received an aggregate of $535,000 in gross proceeds from the Investors through
the initial closing of a private placement issuance of:
| ● | Convertible Notes Promissory
(the “Notes” and each a “Note”); and |
| ● | five-year warrants (the “Warrants”)
to purchase an aggregate 46,521,739 shares of the Company’s common stock (the “Common Stock”) at an exercise price
of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). |
The Notes mature in 12 months,
bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as
adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes may be prepaid at any time without penalty.
The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.
The Notes
and the Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to
the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99%
(the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion
or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event
such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.
Other
than disclosed above, the Company has evaluated subsequent events through the date the consolidated financial statements were available
to be issued and has concluded that no such events or transactions took place that would require disclosure herein.